Skip to content
Dose Brief
Menu
No. 163 on the board · Grade C

Medro review

Medro (Medro Health Technologies, Inc.) is a telehealth brand whose GLP-1 program offers compounded semaglutide and tirzepatide, plus brand-name GLP-1s when eligible, via a partner medical group and…

Visit Medro Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
From $199/mo (compounded)
Tirzepatide
From $299/mo (compounded)
Coverage
All 50 states
Brand-name
Yes
On the trackerNewnew to the tracker, no prior readingNew to the tracker on 1 August 2026. The published line reads From $199/mo (compounded) at our first reading; there is no earlier reading of ours to compare it against yet.

The scorecard

Medro scored on our six Brief Score factors. See the methodology.

Price Stability46/100
Supply Reliability73/100
Transparency68/100
Access Breadth96/100
Clinical Oversight71/100
Track Record64/100

What we like

  • Covers both compounded semaglutide and tirzepatide and can prescribe brand-name GLP-1s when clinically appropriate.
  • LegitScript-certified (seal #50716646), available in all 50 states, with tiered pricing shown before checkout.
  • No membership fee and free expedited shipping on all orders; online intake with no appointment required in many cases.
  • Prices drop with longer commitments (semaglutide to $149/mo, tirzepatide to $224/mo on a 12-month plan).

The caveats

  • Does not name its compounding pharmacy or its clinical partner medical group, so the fulfillment chain is not verifiable.
  • Pricing is described as illustrative and may change by dose, pharmacy availability, and eligibility — final cost shows only at checkout.
  • Very new brand (2026, trademark pending) spanning many verticals, with a short track record in GLP-1 care.
  • Compounded medications are not FDA-approved or therapeutically equivalent to Ozempic, Wegovy, Mounjaro, or Zepbound.

The brief

Best for: Readers who want compounded or brand semaglutide/tirzepatide with transparent tiered pricing and no membership, all 50 states. Medro (Medro Health Technologies, Inc.) is a telehealth brand whose GLP-1 program offers compounded semaglutide and tirzepatide, plus brand-name GLP-1s when eligible, via a partner medical group and…

Ranked #163 of 495 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Closest on the board

The desks scoring nearest Medro — the realistic shortlist if you're weighing it.

Weighing Medro against one desk in particular? We file it head to head with our top-ranked pick in CoreAge Rx vs Medro, and every desk that outranks it is listed on the Medro alternatives board.

More desks we track (24)

464 more are filed too — see every desk we track, ranked.

Pricing, states and verification reflect Medro's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Medro's site. Not medical advice; see our disclosure.

← Back to all rankings